VeriMomIst chymotrypsin in der Schwangerschaft sicher?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for chymotrypsin (CAS 9004-07-3), and I found no peer-reviewed reports of developmental or reproductive toxicity from topical exposure. Available regulatory records describe it as an enzyme/protease (use as food enzyme or laboratory reagent) and list respiratory/irritant hazards in some notifications (typical for enzymes) but not reproductive hazards. Sources: ECHA substance/registration pages and EFSA food-enzyme safety review; no CIR/SCCS or harmonised reproductive flags were identified.
Related ingredients
Frequently asked questions
- Ist chymotrypsin in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for chymotrypsin (CAS 9004-07-3), and I found no peer-reviewed reports of developmental or reproductive toxicity from topical exposure. Available regulatory records describe it as an enzyme/protease (use as food enzyme or laboratory reagent) and list respiratory/irritant hazards in some notifications (typical for enzymes) but not reproductive hazards. Sources: ECHA substance/registration pages and EFSA food-enzyme safety review; no CIR/SCCS or harmonised reproductive flags were identified.
- Ist chymotrypsin während des Stillens sicher?
- No data indicate chymotrypsin is a breastmilk-borne developmental hazard or that topical cosmetic use leads to systemic levels affecting lactation or the nursing infant. Human milk contains endogenous protease inhibitors (including antichymotrypsin), and regulatory reviews (food-enzyme safety) do not report lactation/transfer concerns. Respiratory sensitisation is noted in safety data sheets but does not constitute reproductive/lactation hazard evidence.
- Ist chymotrypsin sicher für Babyhaut?
- There is no evidence of infant-specific reproductive toxicity. As a protein enzyme, chymotrypsin is a large molecule with very limited dermal bioavailability for intact skin, so adult exposure score is 0; however, by your scoring rules infant skin exposure is increased by +1 because baby skin has a less mature barrier and higher surface-area-to-weight, so baby e = 1. No studies show adverse developmental effects from topical cosmetic use in infants.
- Wie bewertet VeriMom chymotrypsin?
- VeriMom bewertet chymotrypsin mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu chymotrypsin?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu chymotrypsin basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.